Fortress Biotech, Inc.
FBIO
$1.81
-$0.02-1.09%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 91.34M | 57.26M | 58.85M | 76.20M | 83.77M |
Total Receivables | 18.33M | 10.40M | 10.85M | 10.69M | 10.12M |
Inventory | 12.50M | 14.43M | 11.79M | 9.69M | 10.58M |
Prepaid Expenses | 4.73M | 7.11M | 2.58M | 4.65M | 12.07M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 1.17M | 2.21M | 2.21M | -- |
Total Current Assets | 126.90M | 90.37M | 86.28M | 103.44M | 116.55M |
|
|||||
Total Current Assets | 126.90M | 90.37M | 86.28M | 103.44M | 116.55M |
Net Property, Plant & Equipment | 16.10M | 17.12M | 17.56M | 18.17M | 22.59M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 30.80M | 31.86M | 17.84M | 18.66M | 19.47M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.27M | 4.87M | 5.41M | 5.42M | 6.03M |
Total Assets | 178.07M | 144.22M | 127.09M | 145.69M | 164.65M |
|
|||||
Total Accounts Payable | 27.82M | 31.64M | 34.03M | 37.96M | 41.80M |
Total Accrued Expenses | 35.87M | 30.74M | 27.04M | 27.75M | 31.77M |
Short-term Debt | -- | -- | -- | -- | 4.02M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.03M | 3.25M | 3.76M | 5.48M | 5.60M |
Total Finance Division Other Current Liabilities | 5.96M | 5.77M | 5.47M | 4.36M | 4.50M |
Total Other Current Liabilities | 5.96M | 5.77M | 5.47M | 4.36M | 4.50M |
Total Current Liabilities | 73.67M | 71.40M | 70.31M | 75.54M | 87.70M |
|
|||||
Total Current Liabilities | 73.67M | 71.40M | 70.31M | 75.54M | 87.70M |
Long-Term Debt | 56.38M | 57.96M | 52.47M | 67.01M | 61.42M |
Short-term Debt | -- | -- | -- | -- | 4.02M |
Capital Leases | 13.82M | 14.75M | 15.29M | 15.93M | 17.62M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.71M | 1.76M | 1.75M | 1.80M | 1.85M |
Total Liabilities | 145.59M | 145.87M | 139.82M | 160.28M | 168.58M |
|
|||||
Common Stock & APIC | 773.70M | 763.60M | 755.26M | 739.11M | 733.31M |
Retained Earnings | -751.45M | -740.87M | -734.10M | -721.24M | -710.29M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 22.25M | 22.73M | 21.16M | 17.87M | 23.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|||||
Total Common Equity | 22.25M | 22.73M | 21.16M | 17.87M | 23.02M |
Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
Total Minority Interest | 10.24M | -24.38M | -33.90M | -32.48M | -26.96M |
Total Equity | 32.49M | -1.64M | -12.74M | -14.60M | -3.94M |
|